Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib

• Marco Caruana, MD,
• Afshin Hatami, MD,
• Danielle Marcoux, MD, FRCPC,
• Sébastien Perreault, MD, FRCPC,
• Catherine C. McCuaig, MD, FRCPC

Affiliations

Marco Caruana, MD

Division of Pediatric Dermatology, CHU Sainte-Justine, University of Montreal, Montreal, Canada; Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, Canada

Afshin Hatami, MD

Division of Pediatric Dermatology, CHU Sainte-Justine, University of Montreal, Montreal, Canada; Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, Canada

Danielle Marcoux, MD, FRCPC

Division of Pediatric Dermatology, CHU Sainte-Justine, University of Montreal, Montreal, Canada; Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, Canada

Sébastien Perreault, MD, FRCPC

Division of Pediatric Neurology, CHU Sainte-Justine, University of Montreal, Montreal, Canada; Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, Canada

Catherine C. McCuaig, MD, FRCPC

Division of Pediatric Dermatology, CHU Sainte-Justine, University of Montreal, Montreal, Canada; Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, Canada; Correspondence to: Catherine C. McCuaig, MD, FRCPC, CHU Sainte Justine Division of Dermatology in Pediatrics, University of Montreal, 3175 chemin Côte Sainte-Catherine, Montreal, Quebec, Canada, H3T 1C5.